Katz Guy, Cook Claire E, Fu Xiaoqing, King Andrew J, Stone John H, Choi Hyon K, Wallace Zachary S
Department of Medicine, Division of Rheumatology, Allergy, and Immunology, Massachusetts General Hospital, 55 Fruit St, Yawkey 4B, Boston, MA, USA.
Department of Medicine, Division of Rheumatology, Allergy, and Immunology, Massachusetts General Hospital, 55 Fruit St, Yawkey 4B, Boston, MA, USA.
Semin Arthritis Rheum. 2025 Feb;70:152609. doi: 10.1016/j.semarthrit.2024.152609. Epub 2024 Dec 19.
Patients with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) face excess mortality compared with the general population. Mortality in clinical epidemiology research is often examined using death certificate diagnosis codes; however, the sensitivity of such codes in AAV is unknown.
We performed a retrospective cohort study using the Mass General Brigham AAV Cohort, including patients with AAV who died between 2002 and 2019. Causes of death were determined by electronic health record (EHR) review (reference gold standard) and via cause of death diagnosis codes on death certificates. We calculated the sensitivity of death certificate diagnosis codes for AAV.
Of 684 patients in the registry, 184 died, 92 (52 %) of whom had adequate EHR data available determine cause of death and 72 (40 %) of whom had both EHR and death certificate data available. Death due to AAV, infection, cardiovascular disease, and cancer occurred in 8 %, 29 %, 5 %, and 18 %, respectively, when ascertained by manual review, as opposed to 0 %, 11 %, 25 %, and 21 %, as determined by death certificates. The sensitivity of AAV diagnosis codes for AAV was 16.6 % (95 % CI: 10.5, 22.6) among all patients with death certificate data available.
In a contemporary cohort of patients with AAV, infection was the most common cause of death, while death due to AAV itself was rare. We found a high degree of discordance between causes of death determined by manual review and death certificate diagnosis codes. Mortality research on AAV should include linkage to medical records data to reduce potential bias.
与普通人群相比,抗中性粒细胞胞浆抗体(ANCA)相关血管炎(AAV)患者面临更高的死亡率。临床流行病学研究中的死亡率通常使用死亡证明诊断代码进行检查;然而,此类代码在AAV中的敏感性尚不清楚。
我们使用麻省总医院布莱根AAV队列进行了一项回顾性队列研究,纳入了2002年至2019年间死亡的AAV患者。通过电子健康记录(EHR)审查(参考金标准)和死亡证明上的死亡原因诊断代码确定死亡原因。我们计算了死亡证明诊断代码对AAV的敏感性。
登记的684例患者中,184例死亡,其中92例(52%)有足够的EHR数据可确定死亡原因,72例(40%)同时有EHR和死亡证明数据。通过人工审查确定,AAV、感染、心血管疾病和癌症导致的死亡分别占8%、29%、5%和18%,而通过死亡证明确定的比例分别为0%、11%、25%和21%。在所有有死亡证明数据的患者中,AAV诊断代码对AAV的敏感性为16.6%(95%CI:10.5,22.6)。
在当代AAV患者队列中,感染是最常见的死亡原因,而AAV本身导致的死亡很少见。我们发现人工审查确定的死亡原因与死亡证明诊断代码之间存在高度不一致。AAV的死亡率研究应包括与医疗记录数据的关联,以减少潜在偏差。